NO20010464L - FremgangsmÕter og preparater for behandling av gastro- øsofagealt-reflukssyndrom - Google Patents

FremgangsmÕter og preparater for behandling av gastro- øsofagealt-reflukssyndrom

Info

Publication number
NO20010464L
NO20010464L NO20010464A NO20010464A NO20010464L NO 20010464 L NO20010464 L NO 20010464L NO 20010464 A NO20010464 A NO 20010464A NO 20010464 A NO20010464 A NO 20010464A NO 20010464 L NO20010464 L NO 20010464L
Authority
NO
Norway
Prior art keywords
preparations
treatment
methods
gastroesophageal reflux
reflux syndrome
Prior art date
Application number
NO20010464A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010464D0 (no
Inventor
John R Mccullough
Thomas P Jerussi
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of NO20010464D0 publication Critical patent/NO20010464D0/no
Publication of NO20010464L publication Critical patent/NO20010464L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20010464A 1998-07-28 2001-01-26 FremgangsmÕter og preparater for behandling av gastro- øsofagealt-reflukssyndrom NO20010464L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/123,892 US6147093A (en) 1996-07-19 1998-07-28 Methods for treating gastroesophageal reflux disease
PCT/US1999/016736 WO2000006165A1 (en) 1998-07-28 1999-07-23 Methods and compositions for treating gastro-esophageal reflux disease

Publications (2)

Publication Number Publication Date
NO20010464D0 NO20010464D0 (no) 2001-01-26
NO20010464L true NO20010464L (no) 2001-03-23

Family

ID=22411520

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010464A NO20010464L (no) 1998-07-28 2001-01-26 FremgangsmÕter og preparater for behandling av gastro- øsofagealt-reflukssyndrom

Country Status (25)

Country Link
US (4) US6147093A (cs)
EP (1) EP1100502A1 (cs)
JP (1) JP2002521448A (cs)
KR (1) KR20010071047A (cs)
CN (1) CN1320036A (cs)
AR (1) AR019947A1 (cs)
AU (1) AU5126099A (cs)
BG (1) BG105218A (cs)
BR (1) BR9912581A (cs)
CA (1) CA2338465A1 (cs)
CO (1) CO5060499A1 (cs)
CZ (1) CZ295776B6 (cs)
EA (1) EA200100188A1 (cs)
EE (1) EE200100051A (cs)
HK (1) HK1041226A1 (cs)
HR (1) HRP20010075A2 (cs)
HU (1) HUP0102979A3 (cs)
ID (1) ID28894A (cs)
IL (1) IL141047A0 (cs)
NO (1) NO20010464L (cs)
NZ (1) NZ509671A (cs)
PL (1) PL345764A1 (cs)
SK (1) SK1202001A3 (cs)
TR (1) TR200100921T2 (cs)
WO (1) WO2000006165A1 (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6147093A (en) * 1996-07-19 2000-11-14 Sepracor Inc. Methods for treating gastroesophageal reflux disease
EP1000029B1 (en) * 1997-07-11 2003-10-01 Janssen Pharmaceutica N.V. (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
US6353005B1 (en) 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
DE10314916A1 (de) 2003-04-01 2004-10-21 Endress + Hauser Flowtec Ag, Reinach Vorrichtung zur Bestimmung und/oder Überwachung des Volumen- und/oder Massenstroms eines Mediums
CA2551171C (en) * 2003-12-23 2012-07-10 Bio-Medisinsk Innovasjon As Modulators of peripheral 5-ht receptors
US8138204B2 (en) * 2004-01-07 2012-03-20 Aryx Therapeutics, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
PT1704146E (pt) 2004-01-07 2010-06-30 Aryx Therapeutics Inc Compostos estereoisoméricos e processos para o tratamento de distúrbios gastrointestinais e do sistema nervoso central
US8524736B2 (en) 2004-01-07 2013-09-03 Armetheon, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US20050160544A1 (en) * 2004-01-26 2005-07-28 Marc Geller Contoured grill brush
JP5308818B2 (ja) * 2005-08-31 2013-10-09 アルメテオン、インコーポレイテッド 胃腸系および中枢神経系障害の治療に有用な立体異性化合物の合成方法および中間体
WO2007149929A1 (en) * 2006-06-23 2007-12-27 Aryx Therapeutics, Inc. Piperidine derivatives for the treatment of gastrointestinal and cns disorders
US10570127B1 (en) 2018-11-05 2020-02-25 Renexxion, Llc Material and methods for the treatment of gastro-intestinal disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962115A (en) * 1981-10-01 1990-10-09 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives
US5057525A (en) * 1981-10-01 1991-10-15 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl) benzamide derivatives
US5137896A (en) * 1981-10-01 1992-08-11 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)benzamide derivatives
EP1170010A3 (en) * 1992-07-07 2004-05-19 Sepracor Inc. Method of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
EP1145715A3 (en) * 1992-07-07 2004-05-19 Sepracor Inc. Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
AU7397194A (en) * 1993-07-06 1995-02-06 Mcneil-Ppc, Inc. H2 antagonist-gastrointestinal motility agent combinations
US5712293A (en) * 1995-06-07 1998-01-27 Sepracor, Inc. Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride
US6147093A (en) * 1996-07-19 2000-11-14 Sepracor Inc. Methods for treating gastroesophageal reflux disease
US5739151A (en) * 1996-07-19 1998-04-14 Sepracor Inc. Method for treating emesis and central nervous system disorders using optically pure (+) norcisapride
EP1000029B1 (en) * 1997-07-11 2003-10-01 Janssen Pharmaceutica N.V. (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders

Also Published As

Publication number Publication date
KR20010071047A (ko) 2001-07-28
US20010020031A1 (en) 2001-09-06
ID28894A (id) 2001-07-12
CN1320036A (zh) 2001-10-31
SK1202001A3 (en) 2001-08-06
HRP20010075A2 (en) 2002-02-28
AR019947A1 (es) 2002-03-27
CO5060499A1 (es) 2001-07-30
EA200100188A1 (ru) 2001-08-27
US6632827B2 (en) 2003-10-14
PL345764A1 (en) 2002-01-02
BR9912581A (pt) 2001-05-02
JP2002521448A (ja) 2002-07-16
CZ295776B6 (cs) 2005-11-16
NO20010464D0 (no) 2001-01-26
NZ509671A (en) 2003-08-29
CZ2001348A3 (cs) 2002-01-16
HUP0102979A3 (en) 2002-01-28
US6242465B1 (en) 2001-06-05
BG105218A (en) 2001-11-30
HUP0102979A2 (hu) 2001-12-28
EE200100051A (et) 2002-06-17
HK1041226A1 (zh) 2002-07-05
EP1100502A1 (en) 2001-05-23
AU5126099A (en) 2000-02-21
CA2338465A1 (en) 2000-02-10
WO2000006165A1 (en) 2000-02-10
US6147093A (en) 2000-11-14
IL141047A0 (en) 2002-02-10
US20040044039A1 (en) 2004-03-04
TR200100921T2 (tr) 2001-10-22

Similar Documents

Publication Publication Date Title
NO994778L (no) Fremgangsmåter og preparater for behandling av inflammatorisk tarmsyndrom
NO994613D0 (no) Fremgangsmaate og preparat til behandling av sövn-apne
NO20004098D0 (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
NO20021382L (no) Fremgangsmåter og mikroorganismer for fremstilling av panto- forbindelser
NO991151D0 (no) Forbindelse og anvendelse derav
DK1112174T3 (da) Isosorbidholdige polyestere og fremgangsmåder til fremstiling heraf
NO971015L (no) Forbindelser og metoder for behandling av cancer
NO985484L (no) FremgangsmÕte og preparat for behandling og forhindring av hyperurikemi
NO983576D0 (no) Brönnbehandlingsfluider og fremgangsmåter
NO20015542L (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO20015516L (no) Preparater og anvendelser av ET743 for behandling av kreft
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO20014314L (no) Blandinger og metoder for behandling av stafylokokkisk infeksjon
NO20023482D0 (no) Fremgangsmåte for behandling av stoffmisbruk
NO20010487D0 (no) Disubstituert maleimidforbindelse og farmasöytisk anvendelse herav
NO20015772L (no) Forbindelser og fremgangsmåter for behandling av post- traumatisk stress-syndrom
NO20033498L (no) Fremgangsmåte for behandling og törking av trevirke
NO20010464L (no) FremgangsmÕter og preparater for behandling av gastro- øsofagealt-reflukssyndrom
NO20033506D0 (no) Parasittdrepende preparater og fremgangsmåter for anvendelse
NO20011537D0 (no) Kjemokinreseptorpeptidvaksiner for behandling og forebygging av diabetes
NO20023737L (no) Fremgangsmåte og preparater for behandling av en inflammatorisk lidelse
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
IS6707A (is) Efnablanda til forvarna og meðhöndlunar á krabbameini
NO985068D0 (no) Vaksiner for behandling av lymfom og leukemi
DK0981349T3 (da) 5-alfa-pregnan-3-beta-ol-20-on-sulfat til behandling af tumorer og CNS sygdomme

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application